Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-11-10
pubmed:abstractText
Combination of bevacizumab and FOLFIRI has currently become one of the standard therapeutic regimens. However, published information is still limited. The objective of the present retrospective observational study is to analyse the response and toxicity of first-line treatment with FOLFIRI+bevacizumab in patients with metastatic colorectal cancer (mCRC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1532-1827
pubmed:author
pubmed:issnType
Electronic
pubmed:day
9
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1536-41
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20940719-Aged, pubmed-meshheading:20940719-Antibodies, Monoclonal, pubmed-meshheading:20940719-Antibodies, Monoclonal, Humanized, pubmed-meshheading:20940719-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20940719-Camptothecin, pubmed-meshheading:20940719-Colonic Neoplasms, pubmed-meshheading:20940719-Colorectal Neoplasms, pubmed-meshheading:20940719-Disease Progression, pubmed-meshheading:20940719-Drug Tolerance, pubmed-meshheading:20940719-Female, pubmed-meshheading:20940719-Fluorouracil, pubmed-meshheading:20940719-Humans, pubmed-meshheading:20940719-Leucovorin, pubmed-meshheading:20940719-Liver Neoplasms, pubmed-meshheading:20940719-Male, pubmed-meshheading:20940719-Middle Aged, pubmed-meshheading:20940719-Neoplasm Metastasis, pubmed-meshheading:20940719-Rectal Neoplasms, pubmed-meshheading:20940719-Retrospective Studies, pubmed-meshheading:20940719-Safety, pubmed-meshheading:20940719-Spain, pubmed-meshheading:20940719-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer.
pubmed:affiliation
Department of Oncology, Complejo Hospitalario Universitario de Santiago, Travesía da Choupana, s/n, 15706 Santiago de Compostela, Spain. rafa.lopez.lopez@gmail.com
pubmed:publicationType
Journal Article, Multicenter Study